Medicure (MCUJF) Non-Current Deffered Revenue (2009 - 2022)
Medicure (MCUJF) recorded quarterly Non-Current Deffered Revenue of $131869.8 in Q4 2022, up 943.97% quarter-over-quarter from $12631.6 in Q1 2022, and up 155.73% on a YoY basis from $51566.8 in Q4 2021.
Medicure (MCUJF) Non-Current Deffered Revenue (2009 - 2022) Analysis & Trends
Medicure's Non-Current Deffered Revenue history runs 14 years deep, the most recent figure standing at $131869.8 for Q4 2022.
- In Q4 2022, Non-Current Deffered Revenue rose 155.73% year-over-year to $131869.8; the TTM figure through Dec 2022 stood at $131869.8 (up 155.73% YoY), while the FY2022 annual figure was $131869.8, up 155.73% from the prior year.
- Non-Current Deffered Revenue was $131869.8 for Q4 2022 at Medicure, up from $12631.6 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $2.4 million in Q1 2018 to a low of $12631.6 in Q1 2022.
- Historically, Non-Current Deffered Revenue has averaged $894692.6 across 5 years, with a median of $737525.1 in 2020.
- Biggest YoY gain for Non-Current Deffered Revenue was 155.73% in 2022; the steepest drop was 94.27% in 2022.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $1.5 million in 2018, then tumbled by 42.22% to $890818.1 in 2019, then plunged by 71.15% to $256963.3 in 2020, then plunged by 79.93% to $51566.8 in 2021, then surged by 155.73% to $131869.8 in 2022.
- The last three Non-Current Deffered Revenue figures came in at $131869.8 (Q4 2022), $12631.6 (Q1 2022), and $51566.8 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Medicure | - | - | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 131,869.83 |
| Mar 31, 2022 | 12,631.61 |
| Dec 31, 2021 | 51,566.85 |
| Sep 30, 2021 | 112,806.12 |
| Jun 30, 2021 | 167,586.59 |
| Mar 31, 2021 | 220,437.65 |
| Dec 31, 2020 | 256,963.31 |
| Sep 30, 2020 | 544,057.16 |
| Jun 30, 2020 | 597,878.07 |
| Mar 31, 2020 | 877,172.03 |
| Dec 31, 2019 | 890,818.07 |
| Sep 30, 2019 | 1.26 Mn |
| Jun 30, 2019 | 1.29 Mn |
| Mar 31, 2019 | 1.42 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Sep 30, 2018 | 2.12 Mn |
| Jun 30, 2018 | 2.25 Mn |
| Mar 31, 2018 | 2.36 Mn |
| Dec 31, 2017 | 2.29 Mn |
| Sep 30, 2017 | 2.59 Mn |